glp 1 agonist news Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care Researchers find GLP-1 medications safe

Furthermore, emerging evidence suggests that GLP-1 receptor agonists may lower the risk of obesity-related cancers

severe rash or itching

Its important to remember that these medications are safe when they are used appropriately

Subgroup analyses were performed for trials using different molecules, in the hypothesis that effects on cancer could be drugspecific, rather than common to the whole class

The combination of reduced carbohydrate intake and slowing of glucose absorption also reduces postprandial glycemia and insulinemia and may be the dominant weight-loss-independent effect on type 2 diabetes and cardiovascular disease

Wadden, T